• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Median number of hours to resolve Severity One outages which occurred within the month (1)

Dictionary: The Office of Information Management provides and manages information technology (IT) and other related services to ensure FDA can carry out its mission of promoting and protecting public health in an efficient, effective, productive, and timely manner. One of the ways OIM ensures that FDA employees are able to sustain a high level of productivity is to resolve IT related issues as quickly as possible. Severity One outages are defined as a global failure where work is halted or a potential halt of work for multiple customers on a floor, building or entire Center. OIM tracks the number of Severity One outages that are received during the month and the median number of hours it took for OIM to resolve the issue. OIM strives to reduce the number of hours it takes to resolve Severity One outages and return services to our customers.

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetMedian
Oct 201035.3
Nov 201033.4
Dec 201031.2
Jan 201131.9
Feb 201131.1
Mar 201131.6
Apr 201133
May 201132.6
Jun 201132.4
Jul 201133.7
Aug 201137.7
Sep 201133.1

Footnotes

  • (1) An outage is resolved when the applicable service ticket is closed.

Number of Severity One outages reported in the month

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetNumber
Oct 2010N/A104
Nov 2010N/A97
Dec 2010N/A81
Jan 2011N/A98
Feb 2011N/A117
Mar 2011N/A161
Apr 2011N/A121
May 2011N/A72
Jun 2011N/A68
Jul 2011N/A45
Aug 2011N/A81
Sep 2011N/A46

FY 2011 Total: 1,091

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.